Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search span> per sponsor: Harry LA Janssen, MD PhD
Woman and Man Max 99 years
Harry LA Janssen, MD PhD
Update Il y a 5 ans
Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study
Background and rationale Chronic hepatitis B is the most common cause of liver cirrhosis and hepatocellular carcinoma worldwide.(1) Antiviral therapy with oral nucleoside analogs and inter...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Harry LA Janssen, MD PhD
Update Il y a 5 ans
Long Term Follow-up of Pegylated-Interferon Alpha-2b
The aim of this study was to investigate the long term outcome of Peginterferon alpha-2b with or without the addition of lamivudine in patients with chronic hepatitis B
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Harry LA Janssen, MD PhD
Update Il y a 5 ans
48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
The purpose of this study is to investigate whether in patients with chronic HBeAg-negative hepatitis B, PEG-IFN-ribavirin combination therapy for 1 year leads to enhanced response (HBV DN...
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Harry LA Janssen, MD PhD
Update Il y a 5 ans
PEG-IFN in HBV Patients With Incomplete Response to NA
Treatment with a nucleoside analogue and subsequent viral decline has shown to partially restore immune hyporesponsiveness in chronic hepatitis B patients. Recent pilot studies investigati...
Country
None
organs
None
Specialty
None
Closed trial
More information